() managing director & CEO Sean Hall visits Proactive's Sydney studio following participation at the Australian Pharmacy Professional Conference & Trade Exhibition (APP2019).
Hall updates on the progress of clinical trials for NRGBiotic™, a nutraceutical already available in pharmacies.
He also discusses a recent heads of agreement (HoA) reached with Canadian pharmaceutical company Pharmascience Inc. for the further development and global distribution of NanaBis™, which is also progressing through clinical trials.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Medlab Clinical Ltd named herein, including the promotion by the Company of Medlab Clinical Ltd in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE